by Admin | Mar 16, 2026 | Careers
EMA says the eXtended EudraVigilance Medicinal Product Dictionary, or XEVMPD, supports pharmacovigilance activities in the EU, and it continues to publish 2026 training dates for the system. EMA’s registration guidance also says organisations need notification of...
by Admin | Mar 16, 2026 | Careers
EMA’s 2026 hands-on EudraVigilance training says participants should be able to apply ISO/ICH E2B(R3) rules to spontaneous and follow-up reports, amendment and nullification reports, parent-child cases, and clinical-trial SUSAR examples. The agenda also includes EVWEB...
by Admin | Mar 16, 2026 | Careers
FDA’s 2026 Good AI Practice principles emphasize context of use, multidisciplinary expertise, data governance, lifecycle management, and clear essential information. That means the regulator is signaling that successful AI use in life sciences depends not only on...
by Admin | Mar 14, 2026 | Careers
It is easy to assume that modern pharmacovigilance careers are moving entirely toward AI, automation, and advanced analytics. But EMA’s 2026 EudraVigilance training agenda is a helpful reminder that foundational reporting skills still matter deeply. EMA’s hands-on...
by Admin | Mar 14, 2026 | Careers
There is growing excitement around AI in pharmacovigilance, but one career lesson is becoming clearer: in regulated environments, tool familiarity is not enough. Professionals who understand how to govern AI — how to define context of use, assess risk, document...
